Headquartered in Bangalore and Delaware, cell therapy startup Eyestem secured $6.4 million in its Series A funding round at a post-money valuation of $46.4 million. The funding was led by three Indian pharma majors- Biological E. Limited, Alkem, NATCO and Anurag and Karan Bagaria, promoters of Kemwell Biopharma. Existing investors...
India Witnesses Surge in Deep Technology Startups
India's startups have begun to focus on technology and product innovation, and are now filing more patents than ever. This trend has created specialist early stage funds which are focused on grooming product innovation startups and headed by venture capitalists with domain expertise as well as entrepreneurial and operational experience....